Cargando…
Cytidine 5′-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma
Glaucoma, a heterogeneous set of progressively degenerative optic neuropathies characterized by a loss of retinal ganglion cells (RGCs) and typical visual field deficits that can progress to blindness, is a neurodegenerative disease involving both ocular and visual brain structures. Although elevate...
Autores principales: | Gandolfi, Stefano, Marchini, Giorgio, Caporossi, Aldo, Scuderi, Gianluca, Tomasso, Livia, Brunoro, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146438/ https://www.ncbi.nlm.nih.gov/pubmed/32197303 http://dx.doi.org/10.3390/nu12030793 |
Ejemplares similares
-
Cytidine 5′-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives
por: Roberti, Gloria, et al.
Publicado: (2015) -
Cytidine-5-diphosphocholine reduces microvascular permeability during experimental endotoxemia
por: Schmidt, Karsten, et al.
Publicado: (2015) -
Impact of cytidine diphosphocholine on oxygenation in client‐owned dogs with aspiration pneumonia
por: Young, Anda A., et al.
Publicado: (2022) -
Cytidine 5′-diphosphocholine administration prevents peripheral neuropathic pain after sciatic nerve crush injury in rats
por: Emril, Dessy R, et al.
Publicado: (2016) -
Cytidine-5-diphosphocholine supplement in early life induces stable increase in dendritic complexity of neurons in the somatosensory cortex of adult rats
por: Rema, V., et al.
Publicado: (2008)